Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
Blood|February 25, 2020
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysisAndrea J Darzi, Samer G Karam, Rana Charide, et al.
Chest|June 19, 2007
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous ThromboembolismVictor F Tapson, Hervé Decousus, Mario Pini, et al.
Blood Advances|June 17, 2020
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessmentAndrea J Darzi, Samer G Karam, Frederick A Spencer, et al.
Journal of Thrombosis and Haemostasis : JTH|February 7, 2026
Surgical and Procedural Bleed Risk Stratification for Anticoagulated Patients Undergoing Planned Surgery: Guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and HemostasisJoseph R Shaw, Jameel Abdulrehman, Steffan Frosi Stella, et al.
JAMA Internal Medicine|October 7, 2021
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical TrialAlex C Spyropoulos, Mark Goldin, Dimitrios Giannis, et al.
Blood|April 7, 2021
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registryDimitrios Giannis, Steven L Allen, James Tsang, et al.
Research and Practice in Thrombosis and Haemostasis|July 15, 2021
Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countriesStefano Barco, Luca Valerio, Andrea Gallo, et al.
Thrombosis and Haemostasis|April 6, 2021
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID TrialMark Goldin, Dimitrios Giannis, Wassim Diab, et al.
The American Journal of Medicine|April 30, 2016
North American Thrombosis Forum, AF Action Initiative Consensus DocumentChristian T Ruff, Jack E Ansell, Richard C Becker, et al.
Thrombosis and Haemostasis|December 7, 2017
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and RationaleJames D Douketis, Alex C Spyropoulos, Julia M Anderson, et al.
Pageof 24